Theranica AI Predicts Next-Day Migraine Risk With 91% Precision
Theranica's AI predicts next-day migraine risk with 91.2% precision, utilizing 30-day headache patterns from Nerivio users.
FDA
TytoCare Wins First-Of-Its-Kind FDA Approval For AI Ear Diagnostic Tool
Israel's TytoCare receives first-of-its-kind FDA authorization for its AI ear diagnostic tool, Tyto Insights ENT Suite, detecting infection signs.
Israeli Medtech Firm IceCure Gains FDA Approval for Post-Market Breast Cancer Study
IceCure Medical's ProSense cryoablation, a minimally invasive breast cancer treatment, is now under FDA review in a post-market study called "ChoICE.".
Pulsenmore Wins First U.S. Client Following FDA Clearance
Israeli company Pulsenmore secures its first U.S. client, the Center for Fetal Medicine in Los Angeles, following FDA clearance for its home pregnancy.
Israeli Innovation Targets Severe Heart Condition: Trisol’s Valve Shows Promising U.S. Trial Outcomes
Israeli Trisol Medical's innovative tricuspid valve replacement system shows promising U.S. trial outcomes for severe heart conditions, improving patient.
Aidoc’s Israeli AI Receives FDA Approval to Speed Emergency Care
Aidoc's Israeli AI receives FDA clearance for a multi-condition solution, speeding up emergency care by analyzing over 100 million patient cases and improving.